Cite

HARVARD Citation

    O'Neil, B. et al. (n.d.). 502 Pembrolizumab (MK-3475) for patients (pts) with advanced colorectal carcinoma (CRC): Preliminary results from KEYNOTE-028. European journal of cancer. pp. S103-. [Online]. 
  
Back to record